Randomized, Double-blind, Placebo/Active-controlled, Multi-center Clinical Trial to Investigate the Safety/Tolerability and Efficacy of Bilastine 20mg After 14-day Oral Administration in Patients With Seasonal Allergic Rhinitis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
The objective of the study was to determine the efficacy and tolerability of 20 mg of Bilastine, compared to Desloratadine and placebo for the treatment of Seasonal Allergic Rhinitis.
Epistemonikos ID: 3a9910661b5123e061b00d51e7d28f8f060d0a77
First added on: May 06, 2024